CXCL6 and hepatocellular carcinoma: using the Oncomine platform, and the results demonstrated that patients with HCC exhibited a higher expression of CXCL1 (1.35-fold, p = 0.003) and CXCL6 (3.75-fold, p = 3.15 × 10−7) than their normal counterparts (Figure 1A).